

Cover Story
By Paul Goldberg and Jacquelyn Cobb
How is the enterprise of cancer research doing after the first 100 days of the Trump administration?
Cancer Policy
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for May 2025
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown
- Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Bhattacharya: New grant review criterion is “not political”
- Population-based cancer surveillance is a national treasure at risk
- Anthony Letai sworn in as 18th NCI director